Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMIZE kidney transplant study
NL-OMON60418Phase 4Completed
- Sponsor
- University Medical Center Groningen
- Start
- Jul 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of basiliximab in kidney transplant, sponsored by University Medical Center Groningen. Primary endpoints: Overall primary endpoint: successful transplantation, Stratum A successful transplantation and 1 more. Started Jul 2019; status: completed.
02
Drugs
basiliximab
03
Conditions
kidney transplant
Beyond the preview
Go deeper on NL-OMON60418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60418.